| |
GS-9883 (non-boosed integrase inhibitor),
F/TAF (emtricitabine/tenofovir alafenamide)
|
| |
| |
Safety and Efficacy of GS-9883 + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults......https://clinicaltrials.gov/ct2/show/NCT02397694
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9883 + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
|
|
| |
| |
|
|
|
